India Pharma Industry Objects To Plan For Increasing Drug Exports
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry is highly critical of a government proposal to increase drug exports with a series of incentives to various firms. The head of the Indian Pharmaceutical Alliance, which represents the industry, said the plan could be counter-productive because it relies on funding initiatives for firms merely registering products with the government. The Department of Pharmaceuticals had proposed funding by venture capitalists and initiatives such as tax exemptions, import duty waivers and protection for clinical test data. (Click here for more